NRX-101

dextromethorphan/quinidine · NeuroRx, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NRX-101, covering 2023-11-13 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression [Phase 2, Phase 3]

See pricing